North America Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

In this region, North America Injectable Drug Delivery Market is projected to reach USD 354.53 billion by 2024 from USD 154.05 billion in 2016, at a CAGR of 5.4% in the forecast period 2017 to 2024.
Based on geography, the North America injectable drug delivery market is segmented into 3 geographical regions, such as,

U.S.,
Mexico,
Canada,

North America injectable drug delivery market competition by top players including -
Becton Dickinson and company is going to dominate the injectable drug delivery market following with Pfizer and Baxter International, Inc., along with others such as
Gerresheimer AG,
Schott AG,
Alkermes Plc.,
Eli Lilly and Company,
Sandoz,
Terumo Corporation,
Teva Pharmaceuticals Industries Ltd.,
Bespak, Antares Pharma,
Elcam Medical,
Haselmeier,
Mylan N.V.,
Novo Nordisk,
Owen Mumford Ltd,
Sanofi,
West Pharmaceutical Services, Inc,
Ypsomed Holding AG.

The North America injectable drug delivery market is segmented on the basis of type, application, usage pattern, mode administration, end user, and distribution channel.

The North America injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation.

Injectable drug delivery device market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases and other diseases on the basis of application.
The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others.

Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.
On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.
On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.

On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.